Implementing the ECDC Action Plan for Measles and Rubella
In recent years, Europe has experienced a resurgence of measles and rubella, and several countries have experienced large outbreaks. The reasons behind this resurgence are complex, but the root cause of the continued measles and rubella transmission in the EU is the sub-optimal uptake of the measles-mumps-rubella (MMR) vaccine, leading to an accumulation of susceptible individuals. ECDC identified five key areas to support Member States in their efforts to achieve the WHO measles and rubella elimination goal: a thorough analysis of the problem, data for action, strengthening of public health capacities, evidence-based communication, and regional and international collaboration.
For each area, specific activities were identified and an ECDC ‘Action Plan for Measles and Rubella’ with more than 20 deliverables was launched in 2012.
This report describes all activities and accomplishments based on the ‘Action Plan for Measles and Rubella’ as of March 2014.
Retrospective surveillance and enhanced case-finding of congenital rubella syndrome cases
16 Nov 2018 - The generic protocol presented in this document was developed for ECDC by fellows of the EPIET programme to provide EU/EEA Member States with an adaptable tool to estimate the incidence of congenital rubella syndrome (CRS) cases in their countries.
Antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in the EU/EEA
30 Mar 2016 - This report is part of an ECDC project on the effectiveness of antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in the EU/EEA.